wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55311366-F03A3C0C-9AC8-4361-BB5E-7ADCBF3CD9A4
Q55311366-F03A3C0C-9AC8-4361-BB5E-7ADCBF3CD9A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55311366-F03A3C0C-9AC8-4361-BB5E-7ADCBF3CD9A4
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism.
P2860
Q55311366-F03A3C0C-9AC8-4361-BB5E-7ADCBF3CD9A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55311366-F03A3C0C-9AC8-4361-BB5E-7ADCBF3CD9A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8180dc150fbdfaaf56427169489f7e715d9e2f68
P2860
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).